Identifying sex-specific biological markers in valvular heart disease
Official title: Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease
Run by The Cleveland Clinic · NCT06780241 · Data updated 2026-11-12
This study is testing if special heart scans can help find different biological markers for men and women with aortic valve disease to improve treatment and recovery after surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | December 10, 2024 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | January 2, 2026 |
| Trial ID | NCT06780241 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-90 with suspected moderate to severe aortic regurgitation or aortic stenosis.
✕Probably not a fit
Patients with acute traumatic cardiac injury, congenital heart diseases, or contraindications to cardiac MRI may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to validate sex-specific biological signatures associated with aortic valve disease using advanced cardiac magnetic resonance (CMR) techniques. By employing methods such as Magnetic Resonance Fingerprinting (MRF), Diffusion Tensor Imaging (DTI), and radiomics analysis, the study seeks to identify predictors of reverse remodeling following aortic valve surgery. The goal is to develop sex-specific thresholds for risk and treatment response, addressing the current lack of consideration for sex differences in existing guidelines for valvular heart disease. The infrastructure created will support a precision medicine approach in cardiovascular imaging.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for patients with valvular heart disease based on their sex.
How similar studies have gone: Other studies have shown success in identifying sex differences in cardiovascular outcomes, suggesting that this approach may yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-90 years of age * Suspected moderate or severe (2-3+ or more) aortic regurgitation, or moderate or more aortic stenosis on the basis of prior known clinical history, echocardiogram or cardiac MRI. Exclusion Criteria: * Acute traumatic cardiac injury * Aortic dissection or aortic root rupture * Congenital heart diseases such as patent ductus arteriosus, coarctation of aorta, ASD and VSD * Presence of A-V fistula or intracardiac shunts * Any contraindications to cardiac MRI including: * Patients with any MR-incompatible implant, including cardiac pacemakers or defibrillators, or older types of cerebral aneurysm clips. * Patients who weigh more than 440 lbs. or have a very wide waist circumference. * Patients with claustrophobia may have difficulty tolerating the exam.
Where it's running
-
Cleveland Clinic
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: Deborah Kwon, MD — The Cleveland Clinic
- Study coordinator: Deborah Kwon, MD
- Email: kwond@ccf.org
- Phone: 216-444-8526
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Surgical implantation of a polymer prosthetic mitral or aortic valve
This will test a surgically implanted polymer heart valve to see if it is safe and works well for adults who need mitral or aortic valve replacement.
-
DELINEATE-Prospective: AI-assisted echocardiogram analysis for valve disease
This project will test whether an AI system can automatically analyze echocardiograms to help doctors detect valve problems in adults who get heart ultrasounds.
-
Comparing imaging methods for heart valve disease assessment
This study is testing whether a new 3D heart imaging method is better than the traditional 2D method for checking how serious heart valve problems are in people with conditions like aortic stenosis and mitral valve regurgitation.
-
Exercise and nutrition support before and after TAVI for older adults with aortic stenosis
This trial tests whether a personalized exercise program plus protein and iron supplements before and after a transcatheter valve replacement can help older adults with aortic stenosis recover better than standard care.
-
Association Between Aortic Valve Area Changes and Pulmonary Congestion After TAVI
This study tests whether improvements in aortic valve opening after TAVI relate to reductions in lung congestion measured by ultrasound in adults with severe aortic stenosis.
-
Systematic 14-day ambulatory heart monitoring after TAVI
After TAVI, patients with certain heart conduction abnormalities will try 14 days of wearable ECG monitoring to see if it lowers the chances of sudden death, symptomatic heart rhythm problems, or stroke within a year compared to standard follow-up.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.